Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2

Status

Active not recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 12Sarcoma 4Gastrointestinal 4Breast 3Head & Neck 2Thoracic 1Gynecologic 1

Conditions

Sarcoma 3Neoplasm Metastasis 1Hemangiosarcoma 1

Interventions

Temozolomide 63Cyclophosphamide 55Radiotherapy 53Bevacizumab 50Doxorubicin 48Ifosfamide 33pazopanib 28fludarabine phosphate 28Etoposide 27Radiation 24Gemcitabine 24pembrolizumab 23Sirolimus 23Sunitinib 22Filgrastim 22Irinotecan 21Whole-Body Irradiation 20Peripheral Blood Stem Cell Transplantation 20Mycophenolic Acid 20Imatinib Mesylate 20Vincristine 19Magnetic Resonance Spectroscopy 18Sorafenib 16Methotrexate 16Busulfan 16Melphalan 15Carboplatin 15Docetaxel 14Cyclosporine 14temsirolimus 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × talimogene laherparepvec × Sarcoma × Clear all
NCT04599062 2026-01-29

TVEC and Preop Radiation for Sarcoma (8 ml Dose)

University of Iowa

Phase 1/2 Active not recruiting
8 enrolled 8 charts
Sarcoma

Sarcoma

NCT03069378 2025-10-29

A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
41 enrolled 8 charts
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT02453191 2024-06-20

TVEC and Preop Radiation for Sarcoma (4 ml Dose)

University of Iowa

Phase 1/2 Completed
30 enrolled 12 charts
Sarcoma

Sarcoma

NCT03921073 2022-11-01

Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
5 enrolled 5 charts
Sarcoma

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡